Md. drug-pricing measures misguided


  State legislation that is intended to impose onerous reporting requirements on drug and therapeutic manufacturers is misguided and potentially harmful to patient access and the biotechnology industry in the state. There are a handful of states, including Maryland, reviewing ...

Read More »

The forecast for podcasts

Glenda LeGendre Big

Podcasts are currently getting increased interest from both listeners and sponsors/advertisers, partially due to the recent focus and fame of the wildly popular programs, “Serial” and “This American Life.” Yet audio programs have been available for streaming or real-time listening ...

Read More »